Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients

Background/Aims: A switch to systemic therapy, such as sorafenib, should be considered for hepatocellular carcinoma (HCC) patients refractory to transarterial chemoembolization (TACE). On the other hand, treatment changes are difficult if the liver function worsens to Child-Pugh B or C. Therefore, p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kang Hyun Park, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung Chul Yoo, Jin Ho Hwang, Sang Woo Park, Young Jun Kim, Hee Sun Park, Mi Hye Yu, Hae Jeong Jeon
Formato: Artigo
Idioma:Inglês
Publicado em: Jin Publishing & Printing Co. 2020-03-01
Colecção:The Korean Journal of Gastroenterology
Assuntos:
carcinoma
hepatocellular
chemoembolization
therapeutic
Acesso em linha:http://www.kjg.or.kr/journal/view.html?uid=5557&vmd=Full&
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados